In PCa cell lines, IGF-1 appears to directly activate the androgen receptor in the absence of androgens, contributing to the failure of androgen deprivation therapy and development of castration-resistant prostate cancer (CRPC). The gene discussed is IGF1; the disease is posterior cortical atrophy.